title: A survey of deep venous thrombosis management by consultant vascular surgeons in the United Kingdom and Ireland.
abstract: OBJECTIVE
  The aim of this study was to detail the current consensus amongst vascular surgeons in Great Britain and Ireland regarding their investigation and management of patients with suspected or proven deep vein thrombosis (DVT).
  
  
  METHODS
  The database of the Vascular Surgical Society of Great Britain and Ireland (VSS) was utilised to send coded postal questionnaires to all consultant surgeon members.
  
  
  RESULTS
  Replies were received from 281 (65%) consultants. Duplex ultrasound is used alone to confirm DVT by 69% of respondents. A thrombophilia screen is always performed by 14% of consultants, for patients with proven DVT, and is more commonly requested by consultants based in a teaching hospital. The majority (57%) of consultants treat DVT with unfractionated heparin (UFH) and warfarin, whereas only 38% utilise low molecular weight heparins (LMWH) and warfarin. A management policy for DVT is reported to be in place by 59%, and a set policy for the specific management of calf vein DVT by just 20%.
  
  
  CONCLUSIONS
  New diagnostic modalities and treatments have been developed for DVT that are more convenient and cost-effective. Although clinical guidelines for the management of patients with DVT are beginning to emerge, there is still a wide discrepancy in many areas of DVT management, and practice at variance with the current evidence base, amongst vascular surgeons in the United Kingdom and Ireland.
authors.affiliation: Department of Vascular and Endovascular Surgery, St James's Hospital, The United Leeds Teaching Hospitals Trust, Leeds, LS9 7TF, UK.
authors.forename: E P
authors.initials: EP
authors.lastname: Turton
authors.forename: P A
authors.initials: PA
authors.lastname: Coughlin
authors.forename: D C
authors.initials: DC
authors.lastname: Berridge
authors.forename: K G
authors.initials: KG
authors.lastname: Mercer
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D020249:Hormone Replacement Therapy; D006801:Humans; D007494:Ireland; D010818:Practice Patterns, Physicians'; D013043:Specialties, Surgical / Q000706:statistics & numerical data*; D019851:Thrombophilia / Q000175:diagnosis; D018616:Ultrasonography, Doppler, Duplex; D006113:United Kingdom; D020246:Venous Thrombosis / Q000628:therapy*; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D006493:Heparin